Q4 2017 Holdings
Filed 2018-02-14 | 23 holdings | $192.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $104.4M | 5,779,506 | 54.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $49.5M | 783,869 | 25.7% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $17.5M | 4,473,607 | 9.1% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $10.8M | 3,367,635 | 5.6% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $9.2M | 142,978 | 4.8% |
| Spectrum Pharmaceuticals Inc | COM | 84763A108 | $139.9K | 7,383,466 | 0.1% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $98.2K | 24,476,520 | 0.1% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $89.2K | 675,492 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $84.2K | 2,649,285 | 0.0% |
| Retrophin Inc | COM | 761299106 | $76.8K | 3,644,438 | 0.0% |
| Mimedx Group Inc(MDXG) | COM | 602496101 | $75.5K | 5,990,682 | 0.0% |
| Pacira Pharmaceuticals Inc(PCRX) | COM | 695127100 | $73.1K | 1,602,334 | 0.0% |
| LA Jolla Pharmaceutical Co(LJPC) | COM PAR $.0001 2 | 503459604 | $66.9K | 2,079,311 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $40.9K | 2,756,012 | 0.0% |
| Nuvasive Inc(NUVAGBP) | COM | 670704105 | $39.5K | 675,000 | 0.0% |
| Stemline Therapeutics Inc | COM | 85858C107 | $36.7K | 2,349,792 | 0.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $34.1K | 916,450 | 0.0% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $18.7K | 7,065,920 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $18.4K | 3,381,303 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $15.6K | 1,119,887 | 0.0% |
| Corindus Vascular Robotics I(CVRSEUR) | COM | 218730109 | $6.0K | 5,986,005 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $1.9K | 232,396 | 0.0% |
| Seaspine Hldgs Corp(SPNEUSD) | COM | 81255T108 | $217 | 21,428 | 0.0% |